Showing results (1171-1180 of 1,203) with videos related to

Sort By:
Pageof 121
The Lancet Regional Health. Europe|January 11, 2023
Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registryGuillaume Favre, Emeline Maisonneuve, Léo Pomar, et al.
Blood Advances|August 30, 2021
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Cédric Rossi, Pierre Sesques, et al.
The Lancet. Haematology|December 15, 2016
Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trialFrançoise Kraeber-Bodere, Amandine Pallardy, Hervé Maisonneuve, et al.
International Journal of Cancer|June 12, 2014
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP projectElena Pasquali, José C García-Borrón, Maria Concetta Fargnoli, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Cancers|October 14, 2022
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic ImplicationsMichele Simbolo, Giovanni Centonze, Luca Giudice, et al.
Oncotarget|July 27, 2016
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter studyEmilie Reboursiere, Fabien Le Bras, Charles Herbaux, et al.
Blood|September 22, 2005
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapyThierry Facon, Jean-Yves Mary, Brigitte Pégourie, et al.
The Journal of Experimental Medicine|June 13, 2024
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupusClémence David, Carlos A Arango-Franco, Mihaly Badonyi, et al.
Trials|October 12, 2023
Minimally invasive versus open pancreatoduodenectomy for pancreatic and peri-ampullary neoplasm (DIPLOMA-2): study protocol for an international multicenter patient-blinded randomized controlled trialNine de Graaf, Anouk M L H Emmen, Marco Ramera, et al.
Pageof 121